Semaglutide was recently licensed in oral form to treat T2D in conjunction with diet and exercise
By enhancing satiety and reducing hunger, tirzepatide makes it easier for patients to stick to a healthy eating plan and achieve long-term weight loss goals
108 Another retrospective study reported that in a population with T2DM and previously diagnosed MASLD/MASH, GLP-1RA is associated with a decreased incidence of hepatocellular carcinoma (HCC) and a reduced risk of hepatic decompensation events compared with other antidiabetic agents
What treatments do Pasadena patients typically choose
Helpful Links References Cheng, J., Nanayakkara, G., Shao, Y., Cueto, R., Wang, L., Yang, W
10.1016/j.ejphar.2024.176600 70 LiuT.CuiY.DongS.KongX.XuX.WangY.et al (2022b)